Glucocorticoid action: A mechanism involving nuclear and non-nuclear pathways

L. K. Johnson, J. P. Longenecker, J. D. Baxter, M. F. Dallman, E. P. Widmaier, N. L. Eberhardt

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The potent anti-inflammatory actions of the corticosteroid hormones have been appreciated by dermatologists since the introduction of synthetic glucocorticoid in 1950. Despite the explosion of knowledge regarding basic cell and molecular biology during the ensuing 30 years, a complete mechanistic picture of how glucocorticoids exert their diverse action on the complex cellular physiology of the skin is lacking. On first consideration, it is not surprising that corticosteroids can inhibit inflammatory responses because inflammation itself is an accelerated metabolic process and glucocorticoids are generally inhibitory on skin cell metabolism. However, a large body of evidence is now accumulating to suggest that glucocorticoids may be much more specific in the manoeuvre through which they exert their anti-inflammatory actions. This idea derives both from the finding of specific receptors for glucocorticoids in cell types derived from skin and the observation of specific responses mediated by defined gene products. However, the induction or inhibition of specific genes cannot explain all of the observed responses of skin elements to glucocorticoid treatment. The following review has, therefore, been organized with respect to a possible mechanism whereby the glucocorticoid receptor can influence both genomic and non-genomic events. Central to this discussion will be the corticosteroid inhibition of prostaglandin production. Data will also be drawn from the glucocorticoid regulation of the pituitary hormones, growth hormone and ACTH.

Original languageEnglish (US)
Pages (from-to)6-23
Number of pages18
JournalBritish Journal of Dermatology
Volume107
Issue numberSuppl. 23
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Glucocorticoids
Adrenal Cortex Hormones
Glucocorticoid Receptors
Skin
Anti-Inflammatory Agents
Skin Physiological Phenomena
Pituitary Hormones
Explosions
Response Elements
Adrenocorticotropic Hormone
Growth Hormone
Genes
Prostaglandins
Cell Biology
Molecular Biology
Observation
Hormones
Inflammation

ASJC Scopus subject areas

  • Dermatology

Cite this

Johnson, L. K., Longenecker, J. P., Baxter, J. D., Dallman, M. F., Widmaier, E. P., & Eberhardt, N. L. (1982). Glucocorticoid action: A mechanism involving nuclear and non-nuclear pathways. British Journal of Dermatology, 107(Suppl. 23), 6-23. https://doi.org/10.1111/j.1365-2133.1982.tb01026.x

Glucocorticoid action : A mechanism involving nuclear and non-nuclear pathways. / Johnson, L. K.; Longenecker, J. P.; Baxter, J. D.; Dallman, M. F.; Widmaier, E. P.; Eberhardt, N. L.

In: British Journal of Dermatology, Vol. 107, No. Suppl. 23, 1982, p. 6-23.

Research output: Contribution to journalArticle

Johnson, LK, Longenecker, JP, Baxter, JD, Dallman, MF, Widmaier, EP & Eberhardt, NL 1982, 'Glucocorticoid action: A mechanism involving nuclear and non-nuclear pathways', British Journal of Dermatology, vol. 107, no. Suppl. 23, pp. 6-23. https://doi.org/10.1111/j.1365-2133.1982.tb01026.x
Johnson LK, Longenecker JP, Baxter JD, Dallman MF, Widmaier EP, Eberhardt NL. Glucocorticoid action: A mechanism involving nuclear and non-nuclear pathways. British Journal of Dermatology. 1982;107(Suppl. 23):6-23. https://doi.org/10.1111/j.1365-2133.1982.tb01026.x
Johnson, L. K. ; Longenecker, J. P. ; Baxter, J. D. ; Dallman, M. F. ; Widmaier, E. P. ; Eberhardt, N. L. / Glucocorticoid action : A mechanism involving nuclear and non-nuclear pathways. In: British Journal of Dermatology. 1982 ; Vol. 107, No. Suppl. 23. pp. 6-23.
@article{6220181c6621467194c83f60df324842,
title = "Glucocorticoid action: A mechanism involving nuclear and non-nuclear pathways",
abstract = "The potent anti-inflammatory actions of the corticosteroid hormones have been appreciated by dermatologists since the introduction of synthetic glucocorticoid in 1950. Despite the explosion of knowledge regarding basic cell and molecular biology during the ensuing 30 years, a complete mechanistic picture of how glucocorticoids exert their diverse action on the complex cellular physiology of the skin is lacking. On first consideration, it is not surprising that corticosteroids can inhibit inflammatory responses because inflammation itself is an accelerated metabolic process and glucocorticoids are generally inhibitory on skin cell metabolism. However, a large body of evidence is now accumulating to suggest that glucocorticoids may be much more specific in the manoeuvre through which they exert their anti-inflammatory actions. This idea derives both from the finding of specific receptors for glucocorticoids in cell types derived from skin and the observation of specific responses mediated by defined gene products. However, the induction or inhibition of specific genes cannot explain all of the observed responses of skin elements to glucocorticoid treatment. The following review has, therefore, been organized with respect to a possible mechanism whereby the glucocorticoid receptor can influence both genomic and non-genomic events. Central to this discussion will be the corticosteroid inhibition of prostaglandin production. Data will also be drawn from the glucocorticoid regulation of the pituitary hormones, growth hormone and ACTH.",
author = "Johnson, {L. K.} and Longenecker, {J. P.} and Baxter, {J. D.} and Dallman, {M. F.} and Widmaier, {E. P.} and Eberhardt, {N. L.}",
year = "1982",
doi = "10.1111/j.1365-2133.1982.tb01026.x",
language = "English (US)",
volume = "107",
pages = "6--23",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "Suppl. 23",

}

TY - JOUR

T1 - Glucocorticoid action

T2 - A mechanism involving nuclear and non-nuclear pathways

AU - Johnson, L. K.

AU - Longenecker, J. P.

AU - Baxter, J. D.

AU - Dallman, M. F.

AU - Widmaier, E. P.

AU - Eberhardt, N. L.

PY - 1982

Y1 - 1982

N2 - The potent anti-inflammatory actions of the corticosteroid hormones have been appreciated by dermatologists since the introduction of synthetic glucocorticoid in 1950. Despite the explosion of knowledge regarding basic cell and molecular biology during the ensuing 30 years, a complete mechanistic picture of how glucocorticoids exert their diverse action on the complex cellular physiology of the skin is lacking. On first consideration, it is not surprising that corticosteroids can inhibit inflammatory responses because inflammation itself is an accelerated metabolic process and glucocorticoids are generally inhibitory on skin cell metabolism. However, a large body of evidence is now accumulating to suggest that glucocorticoids may be much more specific in the manoeuvre through which they exert their anti-inflammatory actions. This idea derives both from the finding of specific receptors for glucocorticoids in cell types derived from skin and the observation of specific responses mediated by defined gene products. However, the induction or inhibition of specific genes cannot explain all of the observed responses of skin elements to glucocorticoid treatment. The following review has, therefore, been organized with respect to a possible mechanism whereby the glucocorticoid receptor can influence both genomic and non-genomic events. Central to this discussion will be the corticosteroid inhibition of prostaglandin production. Data will also be drawn from the glucocorticoid regulation of the pituitary hormones, growth hormone and ACTH.

AB - The potent anti-inflammatory actions of the corticosteroid hormones have been appreciated by dermatologists since the introduction of synthetic glucocorticoid in 1950. Despite the explosion of knowledge regarding basic cell and molecular biology during the ensuing 30 years, a complete mechanistic picture of how glucocorticoids exert their diverse action on the complex cellular physiology of the skin is lacking. On first consideration, it is not surprising that corticosteroids can inhibit inflammatory responses because inflammation itself is an accelerated metabolic process and glucocorticoids are generally inhibitory on skin cell metabolism. However, a large body of evidence is now accumulating to suggest that glucocorticoids may be much more specific in the manoeuvre through which they exert their anti-inflammatory actions. This idea derives both from the finding of specific receptors for glucocorticoids in cell types derived from skin and the observation of specific responses mediated by defined gene products. However, the induction or inhibition of specific genes cannot explain all of the observed responses of skin elements to glucocorticoid treatment. The following review has, therefore, been organized with respect to a possible mechanism whereby the glucocorticoid receptor can influence both genomic and non-genomic events. Central to this discussion will be the corticosteroid inhibition of prostaglandin production. Data will also be drawn from the glucocorticoid regulation of the pituitary hormones, growth hormone and ACTH.

UR - http://www.scopus.com/inward/record.url?scp=0020265811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020265811&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.1982.tb01026.x

DO - 10.1111/j.1365-2133.1982.tb01026.x

M3 - Article

C2 - 6291571

AN - SCOPUS:0020265811

VL - 107

SP - 6

EP - 23

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - Suppl. 23

ER -